At a glance
- Originator Aventis
- Class Antiepileptic drugs; Muscle relaxants; Neuroprotectants
- Mechanism of Action Glycine agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 30 Jan 1997 No-Development-Reported for Epilepsy in USA (PO)